Lifemd reaffirms 2026 guidance of $220M-$230M revenue and $12M-$17M adjusted EBITDA as it targets $250M+ run-rate revenue by Q4 (NASDAQ:LFMD)
LifeMDLifeMD(US:LFMD) Seeking Alpha·2026-05-07 11:04

新闻内容技术访问问题 - 提供的文档内容显示网页访问被阻止，要求用户启用浏览器中的Javascript和cookies，并可能需禁用广告拦截器以继续 [1]

LifeMD-Lifemd reaffirms 2026 guidance of $220M-$230M revenue and $12M-$17M adjusted EBITDA as it targets $250M+ run-rate revenue by Q4 (NASDAQ:LFMD) - Reportify